In vitro fertilization and embryo transfer (IVF/ET): an established and successful therapy for endometriosis

other OA: closed public-domain-us
Full text JSON View on PubMed View at publisher
AI-generated deep summary by claude@2026-07, 2026-07-09 · read from full text

This report describes a 6-year experience of 136 women undergoing 280 IVF/embryo transfer cycles, stratified into prior endometriosis with a normal pelvis at oocyte retrieval, stages I–II endometriosis, and stages III–IV endometriosis. Stimulation protocols and estradiol responses were reported as similar across groups, but group 3 had fewer preovulatory and immature oocytes retrieved and fewer embryos transferred, while fertilization rates and per-cycle/per-transfer pregnancy rates were similar; miscarriage rate was higher and ongoing pregnancy per cycle lower in stages III–IV. Luteal phase estradiol and progesterone levels were comparable, and subgroup analyses within groups 2 and 3 found no differences by number of ovaries or presence/absence of ovarian endometriosis. The paper concludes that minimal/mild endometriosis has excellent IVF/ET outcomes, whereas moderate/severe disease shows compromised reproductive potential, likely from reduced oocyte recovery and poorer embryo quality. This paper is centrally about endometriosis — it reports outcomes of IVF/embryo transfer across endometriosis severity groups.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

The purpose of this report is to present a 6-year experience in the management of endometriosis with in vitro fertilization and embryo transfer (IVF/ET). We divided 136 patients who underwent 280 cycles into three groups: (1) previous history of endometriosis but normal pelvis at the time of oocyte retrieval, (2) stages I-II endometriosis (revised AFS classification), and (3) stages III-IV endometriosis. The stimulation protocols, estradiol (E2) responses, and distribution of terminal E2 patterns were similar in all groups. Group 3 had significantly fewer preovulatory and immature oocytes retrieved and fewer embryos transferred. The fertilization rate and the per cycle/per transfer pregnancy rates were similar in all groups. The miscarriage rate was higher in group 3, and the ongoing pregnancy rate per cycle was lower. Luteal phase E2 and progesterone levels were comparable in all groups. No differences were found when groups 2 and 3 were analyzed for the presence of one or two ovaries or the presence/absence of ovarian endometriosis. The overall fertilization rate, the per cycle/per transfer pregnancy rates, and the miscarriage rate were similar to those of tubal factor patients. We underscore the excellent outcome of patients with minimal or mild endometriosis in IVF/ET. We conclude that patients with moderate or severe endometriosis have a compromised reproductive potential, probably because of a reduced oocyte recovery rate and poor embryo quality.
Full text 7,838 characters · extracted from oa-doi-fallback · 2 sections · click to expand

Abstract

The purpose of this report is to present a 6-year experience in the management of endometriosis with in vitro fertilization and embryo transfer (IVF/ET). We divided 136 patients who underwent 280 cycles into three groups: (1) previous history of endometriosis but normal pelvis at the time of oocyte retrieval, (2) stages I–II endometriosis (revised AFS classification), and (3) stages III–IV endometriosis. The stimulation protocols, estradiol (E2) responses, and distribution of terminal E2 patterns were similar in all groups. Group 3 had significantly fewer preovulatory and immature oocytes retrieved and fewer embryos transferred. The fertilization rate and the per cycle/per transfer pregnancy rates were similar in all groups. The miscarriage rate was higher in group 3, and the on-going pregnancy rate per cycle was lower, Luteal phase E2 and progesterone levels were comparable in all groups. No differences were found when groups 2 and 3 were analyzed for the presence of one or two ovaries or the presencelabsence of ovarian endometriosis. The overall fertilization rate, the per cycle/per transfer pregnancy rates, and the miscarriage rate were similar to those of tubal factor patients. We underscore the excellent out-come of patients with minimal or mild endometriosis in IVF/ET. We conclude that patients with moderate or severe endometriosis have a compromised reproductive potential, probably because of a reduced oocyte recovery rate and poor embryo quality. Similar content being viewed by others

References

Olive DL, Haney AF: Endometriosis-associated infertility: A critical review of therapeutic approaches. Obstet Gynecol Surv 1986;47:538–555 Aral SO, Cates W Jr: The increasing concern with infertility: Why now? Science 1983;250:2327 Schmidt CL: Endometriosis: A reappraisal of pathogenesis and treatment. Fertil Steril 1985;44:157–173 Mahadevan MM, Trounson AD, Leetou JF: The relationship of tubal blockage, infertility of unknown cause, suspected male infertility, and endometriosis to success of in vitro fertilization and embryo transfer. Fertil Steril 1983;40:755–762 Chillik C, Acosta A, Garcia JE, Perera S, Van Uem JF, Rosenwaks Z, Jones HW Jr: The role of in vitro fertilization in infertile patients with endometriosis. Fertil Steril 1985; 44:56–61 Wardle PG, Mitchell JD, McLaughlin EA, Ray BD, McDermott A, Hull MG: Endometriosis and ovulatory disorder: Reduced fertilization in vitro compared with tubal and unexplained infertility. Lancet 1985;2:236–239 O'Shen RT, Chen C, Weiss T, Jones WR: Endometriosis and in vitro fertilization. Lancet 1985;2:723 Matson PL, Yovich JL: The treatment of infertility associated with endometriosis by in vitro fertilization. Fertil Steril 1986;46:432–434 American Fertility Society: Revised classification of endometriosis: 1985. Fertil Steril 1985;43:351–352 Jones HW Jr, Acosta AA, Andrews MC, Garcia JE, Jones GS, Mayer J, Rosenwaks Z, Sandow B, Veeck L, Wilkes C: Three years of in vitro fertilization at Norfolk. Fertil Steril 1984; 42:826–834 Rosenwaks Z, Muasher S, Acosta A: Use of hMG and/or FSH for multiple follicular development. Clin Obstet Gynecol 1986;29:148–157 Veeck L, Maloney M: Insemination and fertilization.In In Vitro Fertilization-Norfolk, HW Jones, Jr, GS Jones, GD Hodgen, Z Rosenwaks (eds). Baltimore, Williams and Wilkins, 1986, pp 168–200 Veeck LL: Extracorporeal maturation: Norfolk. Ann NY Acad Sci 1985;774:357–367 Jones GS, Garcia JE, Rosenwaks Z: The role of pituitary gonadotropins in follicular stimulation and oocyte maturation in the human. JCEM 1984;59:178–180 Jones HW Jr, Acosta A, Andrews MC, Garcia JE, Jones GS, Mantzavinos T, McDowell J, Sandow B, Veeck L, Whibley T, Wilkes C, Wright G: The importance of the follicular phase to success and failure in IVF. Fertil Steril 1983: 40:317–321 Jones HW Jr, Acosta A, Andrews MC, Garcia JE, Jones GS, Mantzavinos T, McDowell J, Sandow B, Veeck L, Whibley T, Wilkes C, Wright C: What is a pregnancy? A question for programs of in vitro fertilization. Fertil Steril 1983;40:728–733 Navot D, Muasher S, Oehninger S, Liu HC, Veeck L, Kreiner D, Rosenwaks Z: The value of in vitro fertilization for the treatment of unexplained infertility. Fertil Steril 1988;49:854–857 Yovich JL, Yovich JM, Tuvik AI, Matson PL, Wilcox DL: In vitro fertilization for endometriosis. Lancet 1985;2:552 Hargrove JT, Abraham CK: Abnormal luteal function in endometriosis. Fertil Steril 1980;34:302 Pittaway DE, Maxson W, daniell J, Herbert C, Wentz AC: Luteal phase defect in infertility patients with endometriosis. Fertil Steril 1983;39:712–713 Muse K, Wilson EA, Jawad MJ: Prolactin hyperstimulation in response to thyrotropin-releasing hormone in patients with endometriosis. Fertil Steril 1982;38:419–422 Ronnberg L, Kaupilla A, Rajaniemi H: Luteinizing hormone receptor disorder in endometriosis. Fertil Steril 1984 85;64–68 Brosens IA, Koninckx PR, Corveleyn PA: A study of plasma progesterone, estradiol 17-β, prolactin and LH levels, and of the appearance of the ovaries in patients with endometriosis and infertility. Br J Obstet Gynecol 1978; 85:246–250 Weed JC, Arquembourg PC: Endometriosis: Can it produce an autoimmune response resulting in infertility? Clin Obstet Gynecol 1980;23:885–893 Dmowski WL, Steele RW, Baker GF: Deficient cellular immunity in endometriosis. Am J Obstet Gynecol 1981; 141:377–383 Rock JA, Dubin NH, Ghodgaonbar RB, Bergquist CA, Erozan YS, Kimball AW Jr: Cul-de-sac fluid in women with endometriosis: Fluid volume and prostanoid concentration during the proliferative phase of the cycle—days 8 to 12 Fertil Steril 1982;37:747–750 Drake TS, O'Brien WF, Ramwell PN, Metz SA: Peritoneal fluid thromboxane B2 and 6-keto-prostaglandin F1 alpha in endometriosis. Am J Obstet Gynecol 1981;140:401–404 Haney AF, Muscato JI, Weinberg JF: Peritoneal cell populations in infertility patients. Fertil Steril 1981;35:696–698 Fabih H, Bagget B, Holtz G, Tsang KY, Lee JC, Williamson HD: Interleukin-1: A possible role in the infertility associated with endometriosis. Fertil Steril 1987;47:213–217 Hill JK, Haimovici F, Politch J, Anderson DJH: The effects of soluble products of activated lymphocytes and macrophages (lymphokines and monokines) on human sperm motion parameters. Fertil Steril 1987;47:460–465 Morcos RN, Gibbons WE, Findley WE: Effect of peritoneal fluid on in vitro cleavage of 2-cell mouse embryos: Possible role in infertility associated with endometriosis. Fertil Steril 1985;44:678–683 Sueldo C, Lambert H, Steinleitner A, Rathwick G, Swanson J: The effect of peritoneal fluid from patients with endometriosis on murine sperm-oocyte interaction. Fertil Steril 1987;48:697–699 Chillik C, Rosenwaks C: Endometriosis and in vitro fertilization. Semin Reprod Endocrinol 1985:3:377–380 Oak MF, Vaughan CA, Elstein: The current status of infertility associated with pelvic endometriosis. Clin Reprod Fertil 1983;2:97 Saifuddin A, Buckley CH, Fox H: Immunoglobulin content of the endometrium in women with endometriosis. Int J Gynecol Pathol 1983;2:255 Kreiner D, Fromowitz F, Richardson D, Kenigsberg D: Endometrial immunofluorescence associated with endometriosis and pelvic inflammatory disease. Fertil Steril 1986: 46:243–246 Groll M: Endometriosis and spontaneous abortion. Fertil Steril 1984;41:933–935 Wheeler JM, Johnston BM, Malinak LR: The relationship of endometriosis to spontaneous abortion. Fertil Steril 1983;39:656–659 Author information Authors and Affiliations Rights and permissions About this article Cite this article Oehninger, S., Acosta, a.A., Kreiner, D. et al. In vitro fertilization and embryo transfer (IVF/ET): An established and successful therapy for endometriosis. J Assist Reprod Genet 5, 249–256 (1988). https://doi.org/10.1007/BF01132172 Received: Accepted: Issue date: DOI: https://doi.org/10.1007/BF01132172

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

MeSH descriptors

Embryo Transfer Endometriosis Endometriosis Fertilization in Vitro Ovarian Neoplasms Pregnancy Complications, Neoplastic Abortion, Spontaneous Abortion, Spontaneous Adult Chorionic Gonadotropin Chorionic Gonadotropin Estradiol Estradiol Female Follicle Stimulating Hormone Follicle Stimulating Hormone Humans Infertility, Female Infertility, Female Luteal Phase

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-08-05T06:13:34.187606+00:00
pubmed
last seen: 2026-05-13T22:09:20.810540+00:00
unpaywall
last seen: 2026-05-14T19:30:52.867331+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine